Strategic Partnerships Leverage existing LVPEI MoU and the Microsoft collaboration to accelerate go to market, distribution, and field training for the 3nethra family and FH POISE AI platform across hospitals, clinics, and eye care programs.

Comprehensive Portfolio Position the full 3nethra lineup along with aberro and Specto as a complete, AI enabled ocular workflow, enabling cross sell and upsell opportunities in clinics, hospitals, and neonatal care centers.

AI Health Advantage Market the FH POISE AI platform for automated detection of diabetic retinopathy, glaucoma, ARMD, and hypertensive retinopathy, with potential expansion into retinal biomarkers for systemic health to attract enterprise and payer customers.

Global Scale Use the wide global footprint and impact as proof points to pursue multinational hospital groups, government eye care programs, and NGO pilots, supported by scalable service and financing options.

Enablement Services Offer bundled services including training, remote diagnostics, and preventive maintenance to reduce entry barriers for clinics adopting high end retinal imaging and AI based diagnostics.